Legend Biotech Company Leadership

LEGN Stock  USD 58.93  0.19  0.32%   
Legend Biotech employs about 2 K people. The company is managed by 15 executives with a total tenure of roughly 4667 years, averaging almost 311.0 years of service per executive, having 133.33 employees per reported executive. Analysis of Legend Biotech's management performance can provide insight into the firm performance.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Legend Biotech Management Team Effectiveness

The company has return on total asset (ROA) of (0.1825) % which means that it has lost $0.1825 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5128) %, meaning that it created substantial loss on money invested by shareholders. Legend Biotech's management efficiency ratios could be used to measure how well Legend Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of July 2024, Return On Tangible Assets is likely to drop to -0.32. In addition to that, Return On Capital Employed is likely to drop to -0.28. At this time, Legend Biotech's Net Tangible Assets are very stable compared to the past year. As of the 22nd of July 2024, Intangible Assets is likely to grow to about 163 M, while Total Assets are likely to drop about 938.8 M.
As of the 22nd of July 2024, Common Stock Shares Outstanding is likely to drop to about 151.5 M. In addition to that, Net Loss is likely to grow to about (381.6 M)

Legend Biotech Workforce Comparison

Legend Biotech Corp is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 2,311. Legend Biotech totals roughly 2,000 in number of employees claiming about 87% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.25.

Legend Biotech Corp Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Legend Biotech Corp Price Series Summation is a cross summation of Legend Biotech price series and its benchmark/peer.

Legend Biotech Notable Stakeholders

A Legend Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Legend Biotech often face trade-offs trying to please all of them. Legend Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Legend Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Elaine QianVP ResourcesProfile
James JDGeneral CounselProfile
Lori CPAChief OfficerProfile
Guowei FangChief DevelopmentProfile
Tina CarterCorporate LeadProfile
Steven GavelUS DevelopmentProfile
Marc HarrisonVP CounselProfile
Liz GosenSenior OperationsProfile
Surabhi VermaManager CommunicationsProfile
Ying HuangCEO DirectorProfile
Yuhong QiuSenior AffairsProfile
Doug WallaceVice OperationsProfile
Alan KickSenior QualityProfile
Joanne ChoiSenior RelationsProfile
Deborah WongExecutive CommunicationsProfile

About Legend Biotech Management Performance

The success or failure of an entity such as Legend Biotech Corp often depends on how effective the management is. Legend Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Legend management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Legend management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.31)(0.32)
Return On Capital Employed(0.27)(0.28)
Return On Assets(0.28)(0.29)
Return On Equity(0.41)(0.43)
The data published in Legend Biotech's official financial statements typically reflect Legend Biotech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Legend Biotech's quantitative information. For example, before you start analyzing numbers published by Legend accountants, it's essential to understand Legend Biotech's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.

Legend Biotech Workforce Analysis

Traditionally, organizations such as Legend Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Legend Biotech within its industry.

Legend Biotech Manpower Efficiency

Return on Legend Biotech Manpower

Revenue Per Employee142.6K
Revenue Per Executive19M
Net Loss Per Employee259.1K
Net Loss Per Executive34.6M
Working Capital Per Employee640.7K
Working Capital Per Executive85.4M

Additional Information and Resources on Investing in Legend Stock

When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.58)
Revenue Per Share
1.902
Quarterly Revenue Growth
1.587
Return On Assets
(0.18)
Return On Equity
(0.51)
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.